Preventive Services for Non-Grandfathered (PPACA) Plans: USPSTF Recommended Services - CAM 089
Description
The U.S. Patient Protection and Affordable Care Act (PPACA) was passed by Congress and signed into law by the president in March 2010. The preventive services component of the law became effective Sept. 23, 2010. A component of the law was a requirement that all “non-grandfathered” health insurance plans are required to cover those preventive medicine services given an “A” or “B” recommendation by the U.S. Preventive Services Task Force (USPSTF).
Plans are not required to provide coverage for the preventive services if they are delivered by out-of-network providers.
Task force recommendations are graded on a five-point scale (A – E), reflecting the strength of evidence in support of the intervention. Grade A: There is good evidence to support the recommendation that the condition be specifically considered in a periodic health examination. Grade B: There is fair evidence to support the recommendation that the condition be specifically considered in a periodic health examination. Grade C: There is insufficient evidence to recommend for or against the inclusion of the condition in a periodic health examination, but recommendations may be made on other grounds. Grade D: There is fair evidence to support the recommendation that the condition be excluded from consideration in a periodic health examination. Grade E: There is good evidence to support the recommendation that the condition be excluded from consideration in a periodic health examination.
Those preventive medicine services listed as Grade A and B recommendations are covered without cost sharing (i.e., deductible, coinsurance, or copay) by Health Plans for appropriate preventive care services provided by an in-network provider. If the primary purpose for the office visit is for other than Grade A or B USPSTF preventive care services, deductible, coinsurance, or copay may be applied.
Services are typically included as part of a normal wellness visit; the appropriate office visit code should be used. Evaluation and Management codes for preventive services 99381 – 99397 will always be considered preventive. CPT codes 99401 – 99404, when used to designate a preventive service, must have the applicable wellness/preventive diagnosis code as the primary reason for the visit.
When the primary purpose of the service is the delivery of an evidence-based service in accordance with a U.S. Preventive Services Task Force A or B rating in effect and other preventive services identified in preventive services mandates (legislative or regulatory), the service may be billed with Modifier ‘-33’.
The correct coding as listed for both ICD-9 and CPT or HCPCS codes in this summary is also required along with Modifier 33. CPT Codes Copyright © 2011 American Medical Association.
Subject to change as regulations and further clarifications are received.
NOTE: THIS POLICY APPLIES ONLY TO NON-GRANDFATHERED PLANS.
Please note that the coding represented in the policy does not take into consideration bundling and editing rules that may apply to them.
Policy:
ABDOMINAL AORTIC ANEURYSM, SCREENING
USPSTF Recommendation
The USPSTF recommends one-time screening for abdominal aortic aneurysm (AAA) screening for men ages 65 – 75 who have ever smoked. (Grade B)
CPT/HCPCS Codes
G0389 — Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening
76706 (effective 1/1/2017) — Ultrasound, abdominal sorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)
ICD-9 Codes
V15.82 — Personal history of tobacco use, presenting hazards to health
V81.2 — Other and unspecified cardiovascular conditions
ICD-10 Codes
Z87891
Z136
ALCOHOL AND DRUG USE SCREENING FOR ADOLESCENTS BEGINNING AT AGE 11 – 18
ANXIETY DISORDERS IN ADULTS: SCREENING ADULTS 64 YEARS OR YOUNGER, INCLUDING PREGNANT AND POSTPARTUM PERSONS:
The USPSTF recommends screening for anxiety disorders in adults , including pregnant and postpartum persons.
CPT/HCPCS codes
CPT 99420 administration and interpretation of health risk assessment instrument
CPT 96160 administration of patient focused health risk assessment instrument
CPT 96161 administration of caregiver focused health risk assessment instrument
HCPCS G0444
ICD 9 V79.0
ICD10 Z1389
ASPIRIN TO PREVENT CARDIOVASCULAR DISEASE IN ADULTS
EFFECTIVE 07012024 THIS BENEFIT WILL TERMINATE AS THE USPSTF HAS DECREASED THIS RECOMMENDATION TO A C/D RECOMMENDATION.
USPSTF Recommendations
The USPSTF recommends the use of aspirin for men age 45 to 79 years when the potential benefit due to a reduction in myocardial infarctions outweighs the potential harm due to an increase in gastrointestinal hemorrhage. (Grade A)
The USPSTF recommends the use of aspirin for women age 55 to 79 years when the potential benefit of a reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (Grade A)
USPSTF recommendation updated April 2016:
The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease and colorectal cancer in adults aged 50 to 59 years who have a 10% or greater 10-year cardiovascular risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years.
Aspirin Use To Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication: Pregnant Persons at High Risk for Preeclampsia:
The USPSTF recommends the use of low-dose aspirin (81 mg/day) as a preventive medication after 12 weeks of gestation in persons who are at high risk for preeclampsia.
Asymptomatic pregnant persons:
The USPSTF recommends screening for hypertensive disorders of pregnancy with blood pressure measurements throughout pregnancy.
ICD 9 V81.1
ICD 10 Z136
CPT 96110
Anxiety in Children and Adolescents: Screening: Children and adolescents aged 8 – 18 years
The USPSTF recommends screening for anxiety in children and adolescents 8 – 18 years
CPT/HCPCS codes
CPT 99420-administration and interpretation of health risk assessment instrument
CPT 96160 administration of patient-focused health risk assessment instrument
CPT 96161 administration of caregiver-focused health risk assessment instrument
CPT 96127 brief emotional/behavioral assessment with scoring and documentation per standardized instrument
HCPCS G0444
ICD9 V79.0
ICD10 Z1389
CPT 87086
ICD-10 Codes
The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing. (grade B)
CPT/HCPCS Codes:
CPT 99385 – 99387
HCPCS S0265
V16.3 — Family history of breast cancer
ICD-10 Codes
Z803
BREAST CANCER, PREVENTIVE MEDICATION
USPSTF Recommendation
CPT Codes
CPT 99401 – 99404
ICD-9 Codes
V16.3
ICD-10 Codes
Z803
BREAST CANCER, SCREENING (MAMMOGRAPHY)
CPT/HCPCS Codes
CPT 77052 (code deleted as of 1/1/2017)
ICD-9 Codes
V76.10 — Breast screening, unspecified
V76.19 — other screening breast examination
ICD-10 Codes
Z1239
CPT/HCPCS Codes
CPT 99401
ICD-9 Codes
V22.0 – V24.2
ICD-10 Codes
Z34 – Z3493
NOTE: CAM 046 also addresses breast pumps and indicates the following two breast pumps are allowable for members who qualify for no cost sharing: the Ameda Purely Yours electric pump and the Ameda One Hand Manual pump.
HRSA (Bright Futures) Recommendation
ICD-9 Codes
V723 — Gynecological exam
ICD-10 Codes
Z01411
CHLAMYDIA INFECTION, SCREENING IN WOMEN AND ADOLESCENTS
USPSTF Recommendation
HRSA (Bright Futures) Recommendation
CPT/HCPCS Codes
ICD-10 Code
COLORECTAL CANCER, SCREENING
USPSTF Recommendation
The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years. (Recommendation changed effective May 18, 2021.)
CPT/HCPCS Codes:
ICD-9 Codes
ICD-10 Codes
CONGENITAL/INHERITED METABOLIC DISORDERS AND HEMOGLOBINOPATHIES
CPT/HCPCS Code
HRSA (Bright Futures) Recommendation
Updated verbiage June 2023:
DEPRESSION AND SUICIDE RISK IN ADULTS: SCREENING ADULTS, INCLUDING PREGNANT AND POSTPARTUM PERSON, AND OLDER ADULTS (65 YEARS OR OLDER)
The USPSTF recommends screening for depression in the adult population, including pregnant and post partum persons, as well as older adults.
CPT/HCPCS Codes
DEPRESSION, SCREENING IN ADOLESCENTS
Updated recommendation 10/2022: Depression and Suicide Risk in children and Adolescents: Screening adolescents aged 12 – 18 years:
The USPSTF recommends screening for major depressive disorder (MDD) in adolescents aged 12 – 18.
CPT /HCPCS Codes
ICD-9 Code
The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (grade B)
FOLIC ACID, PREVENTION OF NEURAL TUBE DEFECTS
Updated verbiage August 2023:
The USPSTF recommends that all persons planning to or who could become pregnant take a daily supplement containing 0.4 to 0.8 (400-800 mcg) of folic acid.
Audiometry screening with 6,000 and 8,000 Hz high frequency is recommended once between 11 through 14 years of age, once between 15 through 17 years of age and once between 18 through 21 years of age.
- Persons born in geographic regions with HBsAg prevalence of > 2%.
- U.S.-born persons not vaccinated as infants whose parents were born in geographic regions with HBsAg prevalence of > 8%.
- Injection-drug users.
- Men who have sex with men.
- Persons with elevated ALT/AST of unknown etiology.
- Persons with selected medical conditions who require immunosuppressive therapy.
- Pregnant women.
- Infants born to HBsAg-positive mothers.
- Household contacts and sex partners of HBV-infected persons.
- Persons who are the source of blood or body fluid exposures that might warrant post-exposure prophylaxis (e.g., needlestick injury to a health care worker).
- Persons infected with HIV.
ICD 10:
Z7251 – Z7253
F11 – F169
F18 – F199
HEPATITIS B VIRUS INFECTION IN PREGNANCY, SCREENING
USPSTF Recommendation
- HIV testing at baseline and every three months while taking PrEP
- Hepatitis B and C testing
- Creatinine testing and calculated estimated creatinine clearance (eCrCL) or glomerular filtration rate (eGFR) to assess kidney function conducted both at baseline and periodically thereafter, consistent with CDC guidelines
- Pregnancy testing, both at baseline and periodically thereafter
- Sexually transmitted infection (STI) screening and counseling
- Adherence counseling
Effective June 2024 the USPSTF verbiage has been updated to state:
High Body Mass Index in Children and Adolescents: Interventions: Children and Adolescents 6 Years or Older:
The USPSTF recommends that clinicians provide or refer children and adolescents 6 years or older with a high body mass index (BMI) (>95 percentile for age and sex) to comprehensive, intensive behavioral interventions.
Recommendation updated August, 2022 to read:
The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater. Grade B
- Atorvastatin 10 mg, 20 mg
- Fluvastatin 20 mg, 40 mg
- Fluvastatin ER 80 mg
- Lovastatin 10 mg, 20 mg, 40 mg
- Pravastatin 10 mg, 20 mg, 40 mg, 80 mg
- Rosuvastatin 5 mg, 10 mg
- Simvastatin 5 mg, 10 mg, 20 mg, 40 mg
- The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and U.S. Food and Drug Administration (FDA)-approved pharmacotherapy for cessation to adults who use tobacco. Grade A
- Tobacco use counseling: pregnant women The USPSTF recommends that clinicians ask all pregnant women about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant women who use tobacco. Grade A
CPT 99408
HCPCS G0396
HCPCS G0443
ICD-9 Codes
V79.1 Screening for alcoholism
ICD-10 Codes
Z1389
Unhealthy Drug Use: Screening Adults Age 18 or Older:
The USPSTF recommends screening by asking questions about unhealthy drug use in adults ages 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.)
VISUAL IMPAIRMENT, SCREENING IN CHILDREN
Procedure and diagnosis codes on Medical Policy documents are included only as a general reference tool for each policy. They may not be all-inclusive.
- Internet Citation: USPSTF A and B Recommendations, U.S. Preventive Services Task Force. August 2019 http://www.uspreventiveservicestaskforce.org/Page/Name/upstf-a-and-b-recommendations/
This medical policy was developed through consideration of peer-reviewed medical literature generally recognized by the relevant medical community, U.S. FDA approval status, nationally accepted standards of medical practice and accepted standards of medical practice in this community and other nonaffiliated technology evaluation centers, reference to federal regulations, other plan medical policies, and accredited national guidelines.
"Current Procedural Terminology © American Medical Association. All Rights Reserved"
History From 2014 Forward
10/31/2024 | Added DX Z2981 to PrEp Section. No other changes made. |
06/24/2024 | Interim review to add: High Body Mass Index in Children and Adolescents: Interventions: children and adolescents 6 years or older: The USPSTF recommends that clinicians provide or refer children and adolescents 6 years or older with a high body mass index (BMI) (>95 percentile for age and sex) to comprehensive, intensive behavioral interventions. This has been added to the obesity section of policy directly following the HRSA Bright Futures recommendation on this topic. |
05/29/2024 | Interim Review, effective 07012024 the coverage criteria for cardiovascular prevention related to low asprin use terminates as USPSTF decrease this recommendation to a C/D recommendation. |
01/09/2024 | Annual review, no change to policy intent. |
09/25/2023 | Interim Review, adding asymptomatic pregnant person screening for hypertension recommendation. |
08/15/2023 | Interim review, adding anxiety disorder screening in adults, updating verbiage to include suicide risk in the depression screening for adults recommendation. Reaffirming latent tuberculosis screening for at risk adults. Updating the folic acid supplementation recommendation to use the ter person/persons. |
06/20/2023 | Updating ICD-10 coding. Effective 10/01/2023, Z298 is being terminated and replace with Z2989. |
01/12/2023 | Annual updating including updating previous recommendations regarding major depression screening in adolescents and adding anxiety screening in children and adolescents. Addition revision to include disclaimer regarding procedure and diagnosis codes potentially not being all inclusive. No other changes. |
10/12/2022 | Adding V76.19 to the mammography section of this policy. No other changes. |
08/24/2022 | Interim review, to add the updated verbiage for the statin use for recommendation to read: The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater. |
08/11/2022 | Interim review, to add G0144 and G0145 to the cervical cancer screening testing. No other changes made. |
05/05/2022 |
Adding USPSTF expanded coverage for colonoscopy effective 05312022. |
01/03/2022 |
Annual review, no change to policy intent. |
10/08/2021 |
Correcting typos, no change to policy intent. |
10/7/2021 |
Correcting coding in HRSA (Bright Futures) Recommendation section. No change to policy intent. |
09/30/2021 |
Interim review, updating veribage related to chlamydia and gonorrhea screening and adding new recommendation related to aspirin and pre eclampsia. |
09/15/2021 |
Interim review, adding recommendation related to healthy weight gain during pregnancy, updating verbiage related to gestational diabetes and recommendation for screening for prediabetes and type 2 diabetes. Adding information to PrEP recommendation. Adding additional diagnosis coding to STI, HIV and Hepatitis recommendations. |
08/16/2021 |
Updating newborn hearing testing coding to include 92652 and 92653. |
06/30/2021 |
Updating high blood pressure screening recommendation to direct reader to the newest hypertension screening recommendation. |
06/09/2021 |
Interim review to add recommendation related to hypertension screening in adults. No other changes. |
05/19/2021 |
Interim review updating colon cancer screening recommendation age limit from 50 to 45 effective 05182021. No other changes made. |
03/30/2021 |
Interim review updating coding: 71271 (effective 01/01/2021) for lung cancer screening. No other changes. |
3/11/2021 |
Interim review updating lung cancer screening criteria age and smoking history: The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. |
02/23/2021 |
Interim review to update the hearing screening verbiage to include: At the 4th, 5th, 6th, 8th and 10th year, audiometry is recommended and Audtiometry screening with 6,000 and 8,000Hz high frequency is recommended once between 11 through 14 years of age, once between 15 through 17 years of age and once between 18 through 21 years of age |
01/13/2021 |
Annual review, no change to policy intent. |
12/14/2020 |
Updating verbiage related to counseling to promote a healthy diet and physical activity to state the most current recommendation verbiage: The USPSTF recommends offering or referring adults with cardiovascular disease risk factors to behavioral counseling interventions to promote a healthy diet and physical activity. |
10/12/2020 |
Interim review to update language in the recommendation on STI counseling. Will state: "The USPSTF recommends behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections (STIs)." Removing the previous verbiage "high intensity" in relation to counseling. No change to coding. |
07/06/2020 |
Interim review to update USPSTF criteria including: update to previous hepatitis C screening to state: The USPSTF recommends screening for hepatitis C virus (HCV) infection in adults ages 18 to 79 years. Also adding tobacco prevention and cessation language that states: The USPSTF recommends that primary care clinicians provide interventions, including education or brief counseling, to prevent initiation of tobacco use among school-aged children and adolescents. Also adding: The USPSTF recommends screening by asking questions about unhealthy drug use in adults ages 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.) |
02/26/2020 |
Interim review to update CPT 96127.96127 is now addressed in relation to depression screening and psychosocial behavioral assessment. No other changes made. |
01/27/2020 |
Annual review, no changes made. |
10/21/2019 |
Interim review to update bacteriuria screening in pregnant women recommendation. The USPSTF has downgraded this recommendation from an A recommendation to a B recommendation. Also updating revised verbiage from USPSTF regarding the recommendation for breast cancer preventive medication. This did not change the intent of the recommendation or the grade of the recommendation. Also adding general disclaimer to policy that the coding represented in the policy does not take into consideration bundling and editing rules that may apply to them. |
09/10/2019 |
Updating recommendation on vision screening by removing ICD coding requirements. Also adding statement that for members 6 years and older, 99174 and 99177 will be considered not medically necessary. |
08/28/2019 |
Interim review to update BRCA verbiage, Hepatitis screening in adolescents and adults and adding verbiage for HIV preexposure prophylaxis. |
06/14/2019 |
Interim review to remove: IRON SUPPLEMENTATION FOR CHILDREN |
04/25/2019 |
Interim review to add Bright Futures verbiage regarding tuberculosis screening and testing. |
04/15/2019 |
Interim review to add USPSTF recommendation: Perinatal depression: counseling and intervention: The USPSTF recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions. No other changes made. |
02/11/2019 |
Interim review to update USPSTF recommendation released 01/31/2019 for gonorrhea prophylactic medication: newborns. |
01/03/2019 |
Annual review, no change to policy intent. |
11/27/2018 |
Updated policy with 2019 coding. No other changes made |
11/21/2018 |
Interim review to update the 2013 recommendation regarding alcohol misuse. No change to intent of recommendation, mirroring the updated USPSTF verbiage. No other changes made. |
10/17/2018 |
Interim review. Adding coverage for CPT code 81528 in the colon cancer screening section of the policy. |
09/11/2018 |
Interim review updating language for colorectal screening to mirror USPSTF language, adding new recommendation language regarding syphilis screening in pregnant women, updating language regarding cervical cancer screening (no change to intent, mirroring USPSTF verbiage) and updating fall-prevention language, which has removed requirements for physical therapy and vitamin D. |
07/23/2018 |
Interim review, adding Z113 and V745 in relation to gonorrhea testing/screening. No other changes made. |
07/11/2018 |
Interim review, adding updated verbiage related to osteoporosis screening from USPSTF (no change to policy intent), adding Bright Futures recommendations regarding newborn bilirubin testing and psychosocial/ behavioral assessments. No other changes. |
04/18/2018 |
Interim Review. Breast Cancer Screening adding codes, G0202 and Human Immunodeficiency virus, counseling and screening deleted code ICD10 Z390-Z392.No other changes. |
04/10/2018 |
Interim review, adding most recent recommendations related to skin cancer behavioral counseling, screening for diabetes mellitus after pregnancy and screening for urinary incontinence in women. No other changes. |
04/04/2018 |
Updating HRSA Bright Futures recommendations: Alcohol & Drug use screening adding 99409, G0442 & G0443, Adding 99401 & 99402 for HIV counseling, editing. |
02/01/2018 |
Annual review |
12/7/2017 |
Add code 0500T to Cervical Cancer Screen. Removed cpt code 88154 per 2018 coding. No other changes. |
11/27/2017 |
Adding code 00812 to Colorectal Cancer, Screening section. |
11/06/2017 |
Adding code V73.81 to coding section. No other change. |
10/11/2017 |
Interim review. Updating Phenylketonuria Screening in Newborns coding section. Updated code V77.3 to V77.7. No change to policy intent. |
09/07/2017 |
Interim review with major revision including addition of numerous Bright Futures recommendations. |
07/21/2017 |
Interim review, adding USPSTF recommendation re: preeclampsia blood pressure screening, adding list of statins to hyperlipidemia section and updating the obesity verbiage related to children and adolescents. |
06/08/2017 |
Interim review to add record review statement for codes 99402 – 99404. |
01/05/2017 |
Annual review, adding most recent USPSTF recommendation related to statin preventive medication, no other changes. |
11/28/2016 |
Updated policy with 2017 codes. |
11/14/2016 |
Interim review adding new USPSTF recommendation related to latent tuberculosis screening. No other changes to policy. |
04/21/2016 |
USPSTF verbiage update from April 2016 added: The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease and colorectal cancer in adults aged 50 to 59 years who have a 10% or greater 10-year cardiovascular risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years and adding new HCPCS code S0285 Colonoscopy consultation performed prior to a screening colonoscopy procedure (effective 07012016). No other changes made. |
03/21/2016 |
Adding Z1151 to Cervical Screening. |
01/13/2016 |
Annual review, no change to policy intent, updating coding to include new codes for 2016. |
12/8/2015 |
Adding new HCPCS codes G0296 & G0297. No other changes made. |
12/1/2015 |
Updating verbiage related to HTN screening: The USPSTF recommends screening for high blood pressure in adults aged 18 years or older. The USPSTF recommends obtaining measurements outside of the clinical setting for diagnostic confirmation before starting treatment. Adding the following verbiage: Diabetes Screening verbiage was updated in October of 2015 to state the following: Adding verbiage related to tobacco counseling |
09/22/2015 |
Added ICD-10 codes to policy. |
06/10/2015 |
Interim review, added verbiage regarding pre eclampsia prevention with aspirin "The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia." |
02/02/2015 |
Added new HCPCS code G0472 to match 86803 in the Hepatitis C section of this policy. |
01/22/2015 |
Corrected typos. |
01/05/2015 |
Updated the name of Patient Protection and Affordable care Act. |
01/01/2015 |
New Policy |